CN Stock MarketDetailed Quotes

603998 Hunan Fangsheng Pharmaceutical

Watchlist

10.35
+0.09+0.88%

Market Closed Jan 3 15:00 CST

4.54BMarket Cap16.64P/E (TTM)

Hunan Fangsheng Pharmaceutical Stock Forum

Moomoo AI

Feb 2, 2024 16:52

The company's low P/E ratio is due to sluggish growth and inferior earnings outlook. Its future prospects are not promising enough to justify a higher P/E ratio.

Investors Don't See Light At End Of Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Tunnel And Push Stock Down 29%

No comment yet

Heat List

Overall

No Data

Investment Theme

Traditional Chinese Medicine Concept